BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/10/2021 7:23:16 AM | Browse: 337 | Download: 492
 |
Received |
|
2021-05-30 12:07 |
|
Peer-Review Started |
|
2021-05-30 12:10 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-06-28 02:16 |
|
Revised |
|
2021-06-28 05:51 |
|
Second Decision |
|
2021-08-16 03:29 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-08-16 05:42 |
|
Articles in Press |
|
2021-08-16 05:42 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-08-24 07:02 |
|
Publish the Manuscript Online |
|
2021-09-10 07:23 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Should people with chronic liver diseases be vaccinated against COVID-19?
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Li-Ping Chen, Qing-Hong Zeng, Yuan-Feng Gong and Fa-Liang Liang |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Fa-Liang Liang, MD, Chief Doctor, Surgeon, Department of General Surgery, Xinxing People’s Hospital, 2nd Chengnanwai New Avenue, Yunfu 527400, Guangdong Province, China. 5598071@qq.com |
| Key Words |
Chronic liver disease; Vaccine; COVID-19; SARS-CoV-2; Hepatic impairment |
| Core Tip |
Chronic liver disease patients co-infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exhibited overexpression of angiotensin-converting enzyme 2 receptors and overwhelming cytokine storm. SARS-CoV-2 vaccines can prevent or alleviate severe infection, and cytokine storm. Recently, a question has been raised whether chronic liver disease patients should be vaccinated against coronavirus disease 2019 (COVID-19). The American Association for the Study of Liver Diseases and European Association for the Study of the Liver Expert Panel suggested that all adult patients with chronic liver disease and liver transplant recipients can receive the COVID-19 vaccines using the standard dose and schedule. |
| Publish Date |
2021-09-10 07:23 |
| Citation |
Chen LP, Zeng QH, Gong YF, Liang FL. Should people with chronic liver diseases be vaccinated against COVID-19? World J Clin Cases 2021; 9(26): 7959-7962 |
| URL |
https://www.wjgnet.com/2307-8960/full/v9/i26/7959.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v9.i26.7959 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
